市场调查报告书
商品编码
1403396
2030 年手术敷料市场预测:按产品、应用、最终用户和地区分類的全球分析Surgical Dressing Market Forecasts to 2030 - Global Analysis By Product, By Application, End User and By Geography |
根据 Stratistics MRC 的数据,2023 年全球手术敷料市场规模为 51 亿美元,预计在预测期内将以 7.6% 的复合年增长率增长,到 2030 年达到 86 亿美元。
手术敷料是指应用于伤口或切口以促进癒合和预防感染的无菌材料。它们由纱布、绷带和胶带组成,用于吸收渗出液、保护伤口免受污染,并维持适当的復健环境。好处包括最大限度地降低感染风险、支持组织修復和提供舒适感。手术敷料对于术后护理、损伤治疗和伤口处理至关重要。
根据美国整形外科医师协会统计,2018年美国约有1,800万人接受了微创整容手术。
慢性病增加
随着糖尿病和心血管疾病等疾病的日益流行,对有效创伤护理和感染预防的需求日益增加。此外,由于人口老化,关节重建和心血管手术等手术数量不断增加。手术敷料在术后护理中发挥着至关重要的作用,提供无菌屏障,最大限度地降低感染风险,并促进最佳创伤治疗。随着世界各地的医疗保健系统应对这些挑战,对先进、高效的手术敷料的需求持续成长。
先进产品高成本
技术先进的手术敷料融合了智慧材料、抗菌剂和先进的创伤治疗技术,通常价格较高。这对普及提出了挑战,特别是在预算有限的医疗保健系统和注重成本的消费者中。患者和医疗保健提供者的经济负担限制了这些先进解决方案的使用,并阻碍了采用更具成本效益的选择。
提高预防感染意识
医疗保健意识的提高强调了创伤护理中预防感染的重要性。这种认识的提高推动了对具有增强抗菌和预防感染特性的先进手术敷料的需求。消费者和医疗保健提供者正在积极寻找不仅能促进创伤治疗还能最大限度地降低感染风险的产品。这一趋势为市场相关人员引入和普及创新手术敷料打开了大门,创造了预防感染至上的市场环境。我们也正在开拓抗菌技术市场的发展,并透过有效且认可的产品来定位市场,以满足不断变化的医疗保健需求。
供应链中断
地缘政治紧张局势、自然灾害和全球流行病等因素可能会扰乱供应链,导致手术敷料关键成分短缺。这些中断不仅影响生产计划,还会导致成本增加和物流挑战。由于对全球供应链的依赖,市场很容易受到製造商无法控制的外部因素的影响。为了减轻这种威胁,产业公司必须投资于弹性供应链管理策略,以实现采购多元化,并制定紧急时应对计画。积极采取措施对于确保材料的稳定供应、维持市场上手术敷料的不间断供应以及防止对患者照护和医疗基础设施的潜在负面影响至关重要。
COVID-19 的爆发对手术敷料市场产生了重大影响,导致世界各地医疗机构对创伤护理产品的需求增加。与病毒相关的住院和手术激增增加了对无菌敷料和先进创伤护理解决方案的需求。此外,大流行加速了远端医疗的采用,并影响了适合远距患者照护的手术敷料的开发。供应链中断、医疗保健优先事项的转变以及医疗保健系统的压力正在进一步影响 COVID-19 期间和之后手术敷料市场的动态。
预计二次选矿产业在预测期间规模最大
二次选矿行业预计将出现良好的成长。二次敷料增加了对主要敷料的保护、渗出物吸收和支撑,以确保最佳的创伤治疗条件。辅助敷料通常用于固定复杂伤口和主要敷料,有多种形式,包括纱布、薄膜、发泡体和亲水胶体。有助于维持无菌环境、预防感染并提高病患舒适度。二次敷料用途广泛且适应性强,使其成为全面伤口护理方案的重要组成部分,满足不同患者的需求并有助于整体积极的结果。
预计医院业在预测期内复合年增长率最高。
预计医院产业在预测期内将以最快的复合年增长率成长。手术敷料对于医院的术后护理、伤口处理和感染预防至关重要。手术量的增加和对感染控制的重视正在推动对先进手术敷料解决方案的需求。医院正在优先考虑使用无菌且有效的敷料,以优化患者的治疗效果。此外,医院和手术敷料製造商之间的持续合作有助于创新产品的开发,满足医疗保健专业人员和患者在不同医疗保健情境中的特定需求。
在预测期内,在强大的医疗基础设施、先进的医疗技术以及需要手术干预的慢性疾病患病率较高的推动下,北美手术敷料市场预计将继续占据大部分市场占有率。该地区拥有完善的法律规范,可确保手术敷料的品质和安全并增强消费者信心。此外,人口老化也导致对术后护理产品的需求增加。持续的技术创新和感染预防意识的提高进一步推动了市场对医疗保健和支持市场生态系统的浓厚兴趣。
预计亚太地区在预测期内复合年增长率最高。人口的成长、医疗保健支出的增加以及对先进创伤护理解决方案的认识不断提高,都有助于市场的扩张。在中国和印度等国家,外科手术的迅速增加和慢性病盛行率的上升正在推动对外科敷料的需求。该地区也正在经历创伤护理产品的创新。随着医疗保健基础设施的改善和对患者治疗结果的重视,亚太地区成为手术敷料製造商的关键市场,为成长和市场渗透提供了机会。
According to Stratistics MRC, the Global Surgical Dressing Market is accounted for $5.1 billion in 2023 and is expected to reach $8.6 billion by 2030 growing at a CAGR of 7.6% during the forecast period. Surgical dressing refers to sterile materials applied to wounds or incisions to promote healing and prevent infection. Comprising gauze, bandages, and adhesive strips, it serves to absorb exudates, protect the wound from contaminants, and maintain a conducive environment for recovery. Advantages include minimizing infection risks, supporting tissue repair, and providing comfort. Surgical dressings are crucial in postoperative care, injury treatment, and wound management.
According to the American Society of Plastic Surgeons, approximately 18 million people in the U.S. underwent minimally invasive cosmetic surgical procedures in 2018.
With an increasing incidence of conditions like diabetes and cardiovascular diseases, there's a heightened need for effective wound care and infection prevention. Additionally, the growing aging population contributes to a higher number of surgeries, such as joint replacements and cardiac procedures. Surgical dressings play a pivotal role in postoperative care by providing a sterile barrier, minimizing infection risks, and promoting optimal wound healing. As healthcare systems globally address these challenges, the demand for advanced and efficient surgical dressing solutions continues to rise.
Technologically advanced surgical dressings incorporating smart materials, antimicrobial agents, and sophisticated wound-healing technologies often come with a higher price tag. This poses a challenge to widespread adoption, particularly in healthcare systems with budget constraints and cost-conscious consumers. The economic burden on patients and healthcare providers limits the accessibility of these advanced solutions, hindering their adoption in favor of more cost-effective alternatives.
As healthcare awareness grows, there is a heightened emphasis on the importance of infection control in wound care. This awareness is driving demand for advanced surgical dressings with enhanced antimicrobial properties and infection-resistant features. Consumers and healthcare providers are actively seeking products that not only facilitate wound healing but also minimize the risk of infections. This trend opens doors for market players to introduce and promote innovative surgical dressing solutions, fostering a market environment where infection prevention is a key consideration. It also encourages the development of antimicrobial technologies, positioning the market to address evolving healthcare needs with effective and awareness-driven products.
Factors such as geopolitical tensions, natural disasters, or global pandemics can disrupt the supply chain, leading to shortages of critical components for surgical dressings. These disruptions not only affect production timelines but also contribute to increased costs and logistical challenges. The dependence on a global supply chain makes the market vulnerable to external factors beyond the control of manufacturers. To mitigate this threat, industry players must invest in resilient supply chain management strategies, diversify sourcing options, and establish contingency plans. Proactive measures are essential to ensure a stable supply of materials and maintain the uninterrupted availability of surgical dressings in the market, safeguarding against potential adverse impacts on patient care and healthcare infrastructure.
The COVID-19 pandemic has significantly impacted the Surgical Dressing Market, leading to increased demand for wound care products in healthcare facilities globally. With a surge in hospitalizations and surgeries related to the virus, there has been a heightened need for sterile dressings and advanced wound care solutions. Additionally, the pandemic has accelerated the adoption of telemedicine, influencing the development of surgical dressings suitable for remote patient care. Supply chain disruptions, fluctuating healthcare priorities, and the strain on healthcare systems have further shaped the dynamics of the surgical dressing market during and post-COVID-19.
The secondary dressing segment is expected to have a lucrative growth. These dressings provide added protection, absorption of exudate, and support to the primary dressing, ensuring optimal wound healing conditions. Commonly used in complex wounds or to secure primary dressings, secondary dressings come in various forms, such as gauze, films, foams, or hydrocolloids. They contribute to maintaining a sterile environment, preventing infections, and promoting patient comfort. The versatility and adaptability of secondary dressings make them integral in comprehensive wound care protocols, catering to diverse patient needs and contributing to overall positive treatment outcomes.
The hospitals segment is anticipated to witness the fastest CAGR growth during the forecast period. Surgical dressings are integral in postoperative care, wound management, and infection prevention within hospital settings. The rising number of surgeries, coupled with a growing emphasis on infection control, propels the demand for advanced surgical dressing solutions. Hospitals prioritize the use of sterile and effective dressings to ensure optimal patient outcomes. Moreover, ongoing collaborations between hospitals and surgical dressing manufacturers contribute to the development of innovative products, addressing the specific needs of healthcare professionals and patients in diverse medical scenarios.
During the forecast period, it is expected that the North American Surgical Dressing market will continue to hold a majority of the market share driven by a robust healthcare infrastructure, advanced medical technologies, and a high prevalence of chronic diseases requiring surgical interventions. The region's well-established regulatory framework ensures the quality and safety of surgical dressings, fostering trust among consumers. Additionally, a growing aging population contributes to an increased demand for postoperative care products. Ongoing technological innovations and the rising awareness of infection prevention further propel the market with a strong focus on healthcare and a supportive market ecosystem.
Asia Pacific is projected to have the highest CAGR over the forecast period. The growing population, increasing healthcare expenditures, and rising awareness about advanced wound care solutions contribute to the market's expansion. In countries like China and India, a surge in surgical procedures, coupled with a higher prevalence of chronic diseases, fuels the demand for surgical dressings. The region also witnesses ongoing technological innovations in wound care products. With improving healthcare infrastructure and a focus on patient outcomes, Asia Pacific represents a key market for surgical dressing manufacturers, presenting opportunities for growth and market penetration.
Some of the key players in Surgical Dressing market include 3M Company, B. Braun SE, Baxter, Smith and Nephew plc., Cardinal Health Inc., Organogenesis Holdings Inc., Coloplast Corp, Molnlycke Health Care AB, Convatec Group PLC, Derma Sciences Inc. (Integra LifeSciences), Essity Aktiebolag AB, Johnson & Johnson Private Limited and Medtronic.
In August 2023, TE Connectivity announced the launch of its new line of hybrid fiber optic connectors.
In April 2023, the FDA clearance for 3M Health Care's 3M Veraflo Therapy, including 3M V.A.C. Veraflo Cleanse Choice Dressing, and 3M Veraflo Cleanse Choice Complete Dressing expanded the company's customer base and increased its revenue. This innovative approach for wound care offered improved treatment options, making it more attractive to healthcare providers and potentially boosting the company's financial performance.
In January 2023, Convatec announced the U.S. launch of ConvaFoam, a family of advanced foam dressings that can be used on a spectrum of wound types at any stage for wound management and skin protection.
In June 2022, Collagen Matrix received 510(k) clearance for a new fibrillar collagen wound dressing. The collagen matrix fibrillar collagen wound dressing is an absorbent microfibrillar matrix used to treat wounds that moderately to extensively exude fluid as well as control mild bleeding.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.